HEADER HYDROLASE 09-APR-09 3H0E TITLE 3,4-DIHYDROPYRIMIDO(1,2-A)INDOL-10(2H)-ONES AS POTENT NON- TITLE 2 PEPTIDIC INHIBITORS OF CASPASE-3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SUBUNITS P17 AND P12; COMPND 5 SYNONYM: CASP-3, APOPAIN, CYSTEINE PROTEASE CPP32, CPP-32, COMPND 6 YAMA PROTEIN, SREBP CLEAVAGE ACTIVITY 1, SCA-1, CASPASE-3 COMPND 7 SUBUNIT P17, CASPASE-3 SUBUNIT P12; COMPND 8 EC: 3.4.22.56; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CASPASE-3, PROTEIN-INHIBITOR COMPLEX, APOPTOSIS, CYTOPLASM, KEYWDS 2 HYDROLASE, PHOSPHOPROTEIN, POLYMORPHISM, PROTEASE, S- KEYWDS 3 NITROSYLATION, THIOL PROTEASE, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR W.XU REVDAT 1 17-NOV-09 3H0E 0 JRNL AUTH L.M.HAVRAN,D.C.CHONG,W.E.CHILDERS,P.J.DOLLINGS, JRNL AUTH 2 A.DIETRICH,B.L.HARRISON,V.MARATHIAS,G.TAWA, JRNL AUTH 3 A.AULABAUGH,R.COWLING,B.KAPOOR,W.XU,L.MOSYAK,F.MOY, JRNL AUTH 4 W.T.HUM,A.WOOD,A.J.ROBICHAUD JRNL TITL 3,4-DIHYDROPYRIMIDO(1,2-A)INDOL-10(2H)-ONES AS JRNL TITL 2 POTENT NON-PEPTIDIC INHIBITORS OF CASPASE-3 JRNL REF BIOORG.MED.CHEM. V. 17 7755 2009 JRNL REFN ISSN 0968-0896 JRNL PMID 19836248 JRNL DOI 10.1016/J.BMC.2009.09.036 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.82 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 38681 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1179 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.8182 - 3.9847 1.00 4945 141 0.1620 0.1794 REMARK 3 2 3.9847 - 3.1670 1.00 4869 150 0.1635 0.1785 REMARK 3 3 3.1670 - 2.7679 0.99 4802 158 0.1870 0.2052 REMARK 3 4 2.7679 - 2.5153 0.98 4779 162 0.1876 0.2091 REMARK 3 5 2.5153 - 2.3354 0.97 4674 148 0.1807 0.2316 REMARK 3 6 2.3354 - 2.1979 0.96 4626 156 0.1824 0.2242 REMARK 3 7 2.1979 - 2.0879 0.94 4532 146 0.2045 0.2440 REMARK 3 8 2.0879 - 1.9970 0.89 4275 118 0.2139 0.2279 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.39 REMARK 3 B_SOL : 63.46 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.370 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.99070 REMARK 3 B22 (A**2) : -0.70660 REMARK 3 B33 (A**2) : 4.69730 REMARK 3 B12 (A**2) : -0.00000 REMARK 3 B13 (A**2) : -12.93250 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3989 REMARK 3 ANGLE : 0.798 5376 REMARK 3 CHIRALITY : 0.057 570 REMARK 3 PLANARITY : 0.003 679 REMARK 3 DIHEDRAL : 15.590 1468 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 39.2066 42.4381 11.8965 REMARK 3 T TENSOR REMARK 3 T11: 0.1955 T22: 0.2012 REMARK 3 T33: 0.1992 T12: -0.0190 REMARK 3 T13: -0.0021 T23: -0.0182 REMARK 3 L TENSOR REMARK 3 L11: 1.7591 L22: 0.7845 REMARK 3 L33: 1.1755 L12: 0.3828 REMARK 3 L13: 0.3934 L23: 0.1222 REMARK 3 S TENSOR REMARK 3 S11: 0.0019 S12: 0.2238 S13: -0.2539 REMARK 3 S21: -0.0709 S22: 0.1183 S23: 0.1412 REMARK 3 S31: 0.0296 S32: -0.0296 S33: 0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): 54.2705 56.8655 26.0164 REMARK 3 T TENSOR REMARK 3 T11: 0.1845 T22: 0.1679 REMARK 3 T33: 0.1617 T12: 0.0035 REMARK 3 T13: 0.0179 T23: -0.0342 REMARK 3 L TENSOR REMARK 3 L11: 1.9204 L22: 0.9276 REMARK 3 L33: 0.9762 L12: 0.3312 REMARK 3 L13: 0.3632 L23: 0.1365 REMARK 3 S TENSOR REMARK 3 S11: -0.1497 S12: -0.1085 S13: 0.1965 REMARK 3 S21: 0.0243 S22: 0.0992 S23: 0.0315 REMARK 3 S31: -0.1346 S32: 0.0840 S33: 0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3H0E COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-09. REMARK 100 THE RCSB ID CODE IS RCSB052533. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-02 REMARK 200 TEMPERATURE (KELVIN) : 143 REMARK 200 PH : 5.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38681 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.997 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.03800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 27.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.22800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.660 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NACITRATE, PH 5.9, 10MM L-CYS, REMARK 280 5% GLYCEROL, 10% PEG3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 62.86950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.97000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 62.86950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.97000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 ILE A 31 REMARK 465 SER A 32 REMARK 465 LEU A 33 REMARK 465 THR A 174 REMARK 465 ASP A 175 REMARK 465 SER A 176 REMARK 465 GLY A 177 REMARK 465 VAL A 178 REMARK 465 ASP A 179 REMARK 465 HIS A 277 REMARK 465 HIS A 278 REMARK 465 HIS A 279 REMARK 465 HIS A 280 REMARK 465 HIS A 281 REMARK 465 HIS A 282 REMARK 465 HIS A 283 REMARK 465 SER B 29 REMARK 465 GLY B 30 REMARK 465 ILE B 31 REMARK 465 SER B 32 REMARK 465 LEU B 33 REMARK 465 ASP B 175 REMARK 465 SER B 176 REMARK 465 GLY B 177 REMARK 465 VAL B 178 REMARK 465 ASP B 179 REMARK 465 HIS B 277 REMARK 465 HIS B 278 REMARK 465 HIS B 279 REMARK 465 HIS B 280 REMARK 465 HIS B 281 REMARK 465 HIS B 282 REMARK 465 HIS B 283 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 120 -178.26 -170.70 REMARK 500 ARG A 144 152.19 -48.88 REMARK 500 ALA A 162 148.06 -172.81 REMARK 500 LYS A 229 -9.97 -155.51 REMARK 500 ASP B 181 76.72 -163.27 REMARK 500 ASP B 192 24.62 86.21 REMARK 500 LYS B 229 -5.86 -150.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 354 DISTANCE = 5.39 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE ORIGINAL REAGENT HAS A DOUBLE BOND BETWEEN O1 AND C5. WHEN REMARK 600 THE REAGENT MAKES A COVALENT BOND WITH CYS, THE DOUBLE BOND REMARK 600 OPENS TO FORM A TETRAHEDRAL CONFIGURATION. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H0E A 1 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H0E B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CP3 RELATED DB: PDB DBREF 3H0E A 29 277 UNP P42574 CASP3_HUMAN 29 277 DBREF 3H0E B 29 277 UNP P42574 CASP3_HUMAN 29 277 SEQADV 3H0E HIS A 278 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS A 279 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS A 280 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS A 281 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS A 282 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS A 283 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS B 278 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS B 279 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS B 280 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS B 281 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS B 282 UNP P42574 EXPRESSION TAG SEQADV 3H0E HIS B 283 UNP P42574 EXPRESSION TAG SEQRES 1 A 255 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 255 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 255 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 255 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 255 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 255 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 255 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 255 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 255 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 255 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 255 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 A 255 ILE GLU THR ASP SER GLY VAL ASP ASP ASP MET ALA CYS SEQRES 13 A 255 HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR ALA TYR SEQRES 14 A 255 SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SER LYS SEQRES 15 A 255 ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA MET LEU SEQRES 16 A 255 LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS ILE LEU SEQRES 17 A 255 THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE GLU SER SEQRES 18 A 255 PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS GLN ILE SEQRES 19 A 255 PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU TYR PHE SEQRES 20 A 255 TYR HIS HIS HIS HIS HIS HIS HIS SEQRES 1 B 255 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 B 255 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 B 255 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 B 255 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 B 255 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 B 255 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 B 255 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 B 255 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 B 255 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 B 255 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 B 255 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 B 255 ILE GLU THR ASP SER GLY VAL ASP ASP ASP MET ALA CYS SEQRES 13 B 255 HIS LYS ILE PRO VAL GLU ALA ASP PHE LEU TYR ALA TYR SEQRES 14 B 255 SER THR ALA PRO GLY TYR TYR SER TRP ARG ASN SER LYS SEQRES 15 B 255 ASP GLY SER TRP PHE ILE GLN SER LEU CYS ALA MET LEU SEQRES 16 B 255 LYS GLN TYR ALA ASP LYS LEU GLU PHE MET HIS ILE LEU SEQRES 17 B 255 THR ARG VAL ASN ARG LYS VAL ALA THR GLU PHE GLU SER SEQRES 18 B 255 PHE SER PHE ASP ALA THR PHE HIS ALA LYS LYS GLN ILE SEQRES 19 B 255 PRO CYS ILE VAL SER MET LEU THR LYS GLU LEU TYR PHE SEQRES 20 B 255 TYR HIS HIS HIS HIS HIS HIS HIS HET H0E A 1 32 HET H0E B 1 32 HETNAM H0E (10S)-3,3-DIMETHYL-8-{[(2S)-2-(PHENOXYMETHYL) HETNAM 2 H0E PYRROLIDIN-1-YL]SULFONYL}-2,3,4,10- HETNAM 3 H0E TETRAHYDROPYRIMIDO[1,2-A]INDOL-10-OL FORMUL 3 H0E 2(C24 H29 N3 O4 S) FORMUL 5 HOH *278(H2 O) HELIX 1 1 HIS A 56 GLY A 60 5 5 HELIX 2 2 GLY A 66 LEU A 81 1 16 HELIX 3 3 THR A 92 LYS A 105 1 14 HELIX 4 4 LEU A 136 ASN A 141 1 6 HELIX 5 5 PHE A 142 ARG A 144 5 3 HELIX 6 6 CYS A 148 THR A 152 5 5 HELIX 7 7 TRP A 214 ALA A 227 1 14 HELIX 8 8 GLU A 231 PHE A 247 1 17 HELIX 9 9 ASP A 253 HIS A 257 5 5 HELIX 10 10 GLY B 66 LEU B 81 1 16 HELIX 11 11 THR B 92 LYS B 105 1 14 HELIX 12 12 LEU B 136 PHE B 142 1 7 HELIX 13 13 CYS B 148 THR B 152 5 5 HELIX 14 14 TRP B 214 ALA B 227 1 14 HELIX 15 15 GLU B 231 PHE B 247 1 17 HELIX 16 16 ASP B 253 HIS B 257 5 5 SHEET 1 A12 GLU A 84 ASN A 89 0 SHEET 2 A12 GLU A 43 ASN A 51 1 N ASN A 51 O LYS A 88 SHEET 3 A12 ARG A 111 LEU A 119 1 O VAL A 117 N ILE A 48 SHEET 4 A12 LYS A 156 GLN A 161 1 O LEU A 157 N PHE A 114 SHEET 5 A12 PHE A 193 TYR A 197 1 O LEU A 194 N PHE A 158 SHEET 6 A12 CYS A 264 SER A 267 -1 O VAL A 266 N TYR A 195 SHEET 7 A12 CYS B 264 SER B 267 -1 O ILE B 265 N SER A 267 SHEET 8 A12 PHE B 193 TYR B 197 -1 N TYR B 195 O VAL B 266 SHEET 9 A12 LYS B 156 GLN B 161 1 N PHE B 158 O LEU B 194 SHEET 10 A12 ARG B 111 LEU B 119 1 N LEU B 118 O ILE B 159 SHEET 11 A12 GLU B 43 ASN B 51 1 N ILE B 48 O VAL B 117 SHEET 12 A12 GLU B 84 ASN B 89 1 O LYS B 88 N ASN B 51 SHEET 1 B 3 GLY A 122 GLU A 123 0 SHEET 2 B 3 ILE A 126 GLY A 129 -1 O ILE A 126 N GLU A 123 SHEET 3 B 3 GLY A 132 ASP A 135 -1 O GLY A 132 N GLY A 129 SHEET 1 C 2 LYS A 186 ILE A 187 0 SHEET 2 C 2 ILE B 172 GLU B 173 -1 O ILE B 172 N ILE A 187 SHEET 1 D 2 ARG A 207 ASN A 208 0 SHEET 2 D 2 GLY A 212 SER A 213 -1 O GLY A 212 N ASN A 208 SHEET 1 E 3 GLY B 122 GLU B 123 0 SHEET 2 E 3 ILE B 126 GLY B 129 -1 O ILE B 126 N GLU B 123 SHEET 3 E 3 GLY B 132 ASP B 135 -1 O GLY B 132 N GLY B 129 SHEET 1 F 2 ARG B 207 ASN B 208 0 SHEET 2 F 2 GLY B 212 SER B 213 -1 O GLY B 212 N ASN B 208 LINK SG CYS A 163 C5 H0E A 1 1555 1555 1.94 LINK SG CYS B 163 C5 H0E B 1 1555 1555 1.95 SITE 1 AC1 12 HIS A 121 GLY A 122 GLU A 123 CYS A 163 SITE 2 AC1 12 THR A 166 TYR A 204 SER A 205 TRP A 206 SITE 3 AC1 12 ARG A 207 SER A 251 PHE A 256 HOH A 304 SITE 1 AC2 10 SER A 58 HIS B 121 GLY B 122 CYS B 163 SITE 2 AC2 10 TYR B 204 SER B 205 TRP B 206 ARG B 207 SITE 3 AC2 10 SER B 251 HOH B 377 CRYST1 125.739 69.940 88.797 90.00 130.08 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007953 0.000000 0.006692 0.00000 SCALE2 0.000000 0.014298 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014718 0.00000